The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of increased systemic inflammation and the risk of cardiovascular disease in endometriosis

Endometriosis occurs in about 5-10 in 100 women of reproductive age. The pathophysiology of endometriosis is controversial. Some studies claimed an association between endometriosis and increased levels of inflammatory factors in peritoneal fluid and/or peripheral blood. Monocyte / HDL cholesterol ratio (MHR) and neutrophil/lymphocyte ratio (NLR) are inflammatory markers and are used as predictors and prognostic indicators of mortality and morbidity in many diseases. In this study, we aimed to investigate whether Monocyte / HDL cholesterol ratio (MHR) and neutrophil/lymphocyte ratio (NLR) are increased in endometriosis as in patients with chronic inflammation and cardiovascular diseases. This is a retrospective case-control study conducted with 87 women, 45 in the endometriosis group and 42 in the control group. The demographic data, biochemical, complete blood count parameters and lipid profile of the cases were recorded and compared between the groups. The mean age of the endometriosis group was 33.88 years and was older than the control group. In terms of other demographic data, there were no difference between the two groups. Although the platelet distribution width and triglyceride values of the endometriosis group were higher than controls, they were interpreted as clinically insignificant. There were no significant differences between the groups in terms of other laboratory parameters including MHR and NLR. In this study, MHR and NLR are found similar in endometriosis and control groups. Further studies are needed to investigate the relationship between increased systemic inflammation.

[1]  Nan Zhang,et al.  Inflammatory and Hematological Indices as Simple, Practical Severity Predictors of Microdysfunction Following Coronary Intervention: A Systematic Review and Meta-Analysis , 2020, Angiology.

[2]  Zhongwei Zhu,et al.  Evaluation of platelet distribution width in hypertension with hyperhomocysteinemia , 2019, Clinical and experimental hypertension.

[3]  A. Usta,et al.  Could hematologic parameters be useful biomarkers for the diagnosis of endometriosis? , 2019, Bratislavske lekarske listy.

[4]  A. Rocha,et al.  New biomarkers in endometriosis. , 2019, Advances in clinical chemistry.

[5]  F. Batteux,et al.  Immunology of endometriosis. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[6]  A. Usta,et al.  The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome , 2018, Reproductive Biology and Endocrinology.

[7]  M. Akboga,et al.  Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. , 2017, Biomarkers in medicine.

[8]  A. Fassbender,et al.  Evaluation of Total, Active, and Specific Myeloperoxidase Levels in Women with and without Endometriosis , 2017, Gynecologic and Obstetric Investigation.

[9]  F. Dede,et al.  The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension , 2017, Hypertension Research.

[10]  H. Kisacik,et al.  Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. , 2016, Heart, lung & circulation.

[11]  D. Aras,et al.  Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[12]  P. Toth Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease , 2016, Vascular health and risk management.

[13]  E. Rimm,et al.  Endometriosis and Risk of Coronary Heart Disease , 2016, Circulation. Cardiovascular quality and outcomes.

[14]  P. Santulli,et al.  Measurement of hs-CRP is irrelevant to diagnose and stage endometriosis: prospective study of 834 patients. , 2014, American journal of obstetrics and gynecology.

[15]  P. Vercellini,et al.  Endometriosis: pathogenesis and treatment , 2014, Nature Reviews Endocrinology.

[16]  A. Prentice,et al.  ESHRE guideline: management of women with endometriosis. , 2014, Human reproduction.

[17]  S. Dilbaz,et al.  Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. , 2013, Journal of the Turkish German Gynecological Association.

[18]  S. Cremers,et al.  Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. , 2012, Cell stem cell.

[19]  R. Ferriani,et al.  Unfavorable lipid profile in women with endometriosis. , 2010, Fertility and sterility.

[20]  F. Geissmann,et al.  Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.

[21]  R. Gold,et al.  Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. , 2009, Critical reviews in immunology.

[22]  I. Sekine,et al.  REVIEW ARTICLE: Immunopathogenesis of Pelvic Endometriosis: Role of Hepatocyte Growth Factor, Macrophages and Ovarian Steroids , 2008, American journal of reproductive immunology.

[23]  P. Wilson,et al.  Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. , 2008, The American journal of medicine.

[24]  O. Erel,et al.  Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. , 2007, Human reproduction.

[25]  V. Georgoulias,et al.  Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls , 1994, Archives of Gynecology and Obstetrics.

[26]  Sajal Gupta,et al.  Role of oxidative stress in endometriosis. , 2006, Reproductive biomedicine online.

[27]  A. Agarwal,et al.  Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. , 2002, Human reproduction.

[28]  N. Dhalla,et al.  Role of oxidative stress in cardiovascular diseases , 2000, Journal of hypertension.

[29]  J. Lessing,et al.  Do Soluble Cell Adhesion Molecules Play a Role in Endometriosis? , 2000, American journal of reproductive immunology.

[30]  C. C. Hsu,et al.  The expression of soluble intercellular adhesion molecule-1 in endometriosis. , 1998, Fertility and sterility.

[31]  L. Racioppi,et al.  Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. , 1998, Human reproduction.

[32]  J. Pinotti,et al.  The use of biochemical markers in the diagnosis of pelvic endometriosis. , 1997, Human reproduction.

[33]  A. Lemay,et al.  Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. , 1996, Human reproduction.

[34]  L. Fong,et al.  High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. , 1990, Biochimica et biophysica acta.